| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
427 |
394 |
$150K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
1,671 |
1,548 |
$46K |
| 92134 |
|
2,646 |
2,540 |
$29K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
575 |
567 |
$23K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
433 |
414 |
$8K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
224 |
219 |
$8K |
| 92226 |
|
645 |
556 |
$7K |
| J9035 |
Injection, bevacizumab, 10 mg |
219 |
206 |
$5K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
107 |
97 |
$3K |
| 92202 |
|
547 |
532 |
$2K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
13 |
13 |
$841.46 |
| 92250 |
|
38 |
37 |
$422.07 |
| 92225 |
|
15 |
12 |
$295.72 |
| 92201 |
|
16 |
15 |
$47.69 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
413 |
407 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
15 |
14 |
$0.00 |
| G9974 |
Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity |
84 |
82 |
$0.00 |
| 1036F |
|
177 |
172 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
302 |
297 |
$0.00 |
| 4177F |
|
64 |
64 |
$0.00 |
| 2019F |
|
22 |
22 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
13 |
13 |
$0.00 |